跳至主要内容
临床试验/TCTR20201223008
TCTR20201223008尚未招募2 期

Effects of Melatonin on Bone Metabolism in Thalassemia Patients with Low Bone Mineral Density (Randomized Controlled Study)

Faculty of Medicine, Chiang Mai university0 个研究点目标入组 64 人开始时间: 2020年12月23日最近更新:
适应症

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
64

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
19 Years 至 50 Years(—)
性别
All

入选标准

  • 1. Male or premenopausal female with age 19-50 years
  • 2. Thalassemia disease, either TDT or NTDT, confirmed by hemoglobin typing (High Performance Liquid Chromatography method) or PCR for thalassemia gene result
  • 3. Iron overload defined as serum ferritin more than 1,000 ng/ml in TDT or 800 ng/ml in NTDT
  • 4. The axial BMD is less than -2 standard deviation of the reference value for that age (Z-score < -2.0)
  • 5. Physically fit defined as ECOG performance status 0-1

排除标准

  • 1. Currently use or history of any bone modifying agent use within 1 year before enrollment: bisphosphonates, RANKL inhibitor, sclerostin inhibitor, SERMs, strontium ranelate (not include calcium and vitamin D)
  • 2. Pregnancy or breastfeeding
  • 3. History of allergy or severe adverse event from melatonin
  • 4. Cannot evaluate BMD by DXA at L-spine and hips

研究者

发起方
Faculty of Medicine&#44; Chiang Mai university

相似试验